Azura Ophthalmics Announces Participation at the 2023 SVB Securities Global Biopharma Conference
TEL AVIV, Israel & MELBOURNE, Australia--(BUSINESS WIRE)--Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a…
TEL AVIV, Israel & MELBOURNE, Australia--(BUSINESS WIRE)--Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a…
Gary Gysin to retire; Dr. Brian Yutko selected as new Chief Executive Officer, Effective February…
Partnership with Industry Leaders Natura, Golden Triangle Health and Great Earth International Ushers Cookies Into…
Tim Beastrom appointed as Chief Legal Counsel and Joel Wasserman as Vice President, Corporate Communications…
DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Robotic Arms Market Outlook And Forecast To 2027 - Driven by…
The global Syngas & Derivatives market size was valued at 245,472 MWth in 2021 and…
DENVER--(BUSINESS WIRE)--Gold Resource Corporation (NYSE American: GORO) (the “Company”) sold a total of 30,119 ounces…
SolarEdge battery cells are manufactured at Sella 2, the Company’s new battery cell manufacturing facility…
Appointing as the Regional Director of LATAM, Chrysanthi Papacharalambous brings more than 15 years of…
Global phase III with 605 patients from the US and eight European countries demonstrates therapeutic…